2021
Drug and alcohol treatment utilization and barriers among Black, American Indian/Alaskan Native, Latine, Asian/Pacific Islander/Native Hawaiian, and White adults: Findings from NESARC-III
Haeny AM, Oluwoye O, Cruz R, Iheanacho T, Jackson AB, Fisher S, Crouch M, O'Malley S. Drug and alcohol treatment utilization and barriers among Black, American Indian/Alaskan Native, Latine, Asian/Pacific Islander/Native Hawaiian, and White adults: Findings from NESARC-III. Journal Of Substance Use And Addiction Treatment 2021, 131: 108569. PMID: 34393011, PMCID: PMC9084614, DOI: 10.1016/j.jsat.2021.108569.Peer-Reviewed Original ResearchConceptsAI/AN adultsAlcohol treatment utilizationAI/ANsTreatment utilizationAlcohol use disorderWhite adultsBlack adultsDUD treatmentLifetime alcohol use disorderAmerican Indians/Alaska NativesAmerican Indian/Alaskan NativeHealth care professionalsNational Epidemiological SurveyEthnic groupsNative HawaiiansOutpatient programEpidemiological dataCare professionalsUse disordersAUD treatmentEpidemiological surveySecondary analysisSocial determinantsRelated conditionsNESARC-III
2020
Underserved Populations
Iheanacho T, Jordan A, Dike C. Underserved Populations. 2020, 289-304. DOI: 10.1007/978-3-030-33404-8_18.Peer-Reviewed Original Research
2013
Long-acting injectable depot naltrexone use in the Veterans' Health Administration: A national study
Marienfeld C, Iheanacho T, Issa M, Rosenheck RA. Long-acting injectable depot naltrexone use in the Veterans' Health Administration: A national study. Addictive Behaviors 2013, 39: 434-438. PMID: 23790742, DOI: 10.1016/j.addbeh.2013.05.006.Peer-Reviewed Original ResearchMeSH KeywordsAlcohol-Related DisordersComorbidityDelayed-Action PreparationsDiagnosis, Dual (Psychiatry)Drug PrescriptionsDrug UtilizationFemaleHospitalizationHumansLogistic ModelsMaleMental DisordersMental Health ServicesMiddle AgedMultivariate AnalysisNaltrexoneNarcotic AntagonistsPsychiatric Department, HospitalRural PopulationSocioeconomic FactorsSubstance-Related DisordersUnited StatesUnited States Department of Veterans AffairsUrban PopulationVeteransConceptsPatient populationOutpatient mental health service useHealth AdministrationMental health inpatient admissionsMental health service useAxis 1 psychiatric disordersStepwise multivariate logistic regressionHealth service useMultivariate logistic regressionVeterans Health AdministrationLarger patient populationLogistic regression analysisAlcohol use disorderPsychotropic prescriptionsInpatient admissionsNaltrexone useUse populationPsychiatric disordersService useUse disordersDepot naltrexoneBivariate analysisLogistic regressionMedicationsNaltrexoneUse of naltrexone for alcohol use disorders in the Veterans’ Health Administration: A national study
Iheanacho T, Issa M, Marienfeld C, Rosenheck R. Use of naltrexone for alcohol use disorders in the Veterans’ Health Administration: A national study. Drug And Alcohol Dependence 2013, 132: 122-126. PMID: 23434041, DOI: 10.1016/j.drugalcdep.2013.01.016.Peer-Reviewed Original ResearchConceptsMultivariate logistic regression analysisAlcohol use disorderCo-morbid Axis INaltrexone prescriptionLogistic regression analysisUse disordersOutpatient visitsClinical usefulnessAxis IHealth AdministrationVeterans Administration Healthcare SystemBivariate analysisSpecialty mental health careProportion of patientsUse of naltrexonePsychiatric outpatient visitsVeterans Health AdministrationAlcohol use disorder diagnosisMental health careRegression analysisNational administrative dataOpioid medicationsBaseline characteristicsRate of useClinical factors